Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-064451
Filing Date
2021-12-09
Accepted
2021-12-09 17:11:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea151934-s1_pasitheathe.htm S-1 1250291
2 OPINION OF MCDERMOTT WILL & EMERY LLP ea151934ex5-1_pasitheathe.htm EX-5.1 8235
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MARCUM LLP) ea151934ex23-1_pasitheathe.htm EX-23.1 2272
4 GRAPHIC image_001.jpg GRAPHIC 38079
5 GRAPHIC image_003.jpg GRAPHIC 3374
  Complete submission text file 0001213900-21-064451.txt   1319106
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-261573 | Film No.: 211482746
SIC: 2834 Pharmaceutical Preparations